Clinical Trial Update: Multiple Doses of DM199 in Patients With Chronic Kidney Disease (REDUX) [Phase 2]

View source ↗

Summary

Phase 2 trial update for DM199 in chronic kidney disease has completed enrollment and status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• DM199

Snippet

Sponsor: DiaMedica Therapeutics Inc | Conditions: Kidney Diseases | Phase 2 | Status: COMPLETED